1. Home
  2. GOCO vs INTS Comparison

GOCO vs INTS Comparison

Compare GOCO & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GoHealth Inc.

GOCO

GoHealth Inc.

HOLD

Current Price

$1.14

Market Cap

17.7M

Sector

Finance

ML Signal

HOLD

Logo Intensity Therapeutics Inc.

INTS

Intensity Therapeutics Inc.

HOLD

Current Price

$5.22

Market Cap

19.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GOCO
INTS
Founded
2001
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.7M
19.2M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
GOCO
INTS
Price
$1.14
$5.22
Analyst Decision
Buy
Buy
Analyst Count
3
3
Target Price
$4.75
$38.00
AVG Volume (30 Days)
53.5K
25.1K
Earning Date
05-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$361,845,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$77.47
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.00
$0.19
52 Week High
$10.56
$8.06

Technical Indicators

Market Signals
Indicator
GOCO
INTS
Relative Strength Index (RSI) 41.27 42.45
Support Level $1.00 $5.04
Resistance Level $1.35 $8.06
Average True Range (ATR) 0.10 0.25
MACD 0.02 -0.03
Stochastic Oscillator 49.28 25.33

Price Performance

Historical Comparison
GOCO
INTS

About GOCO GoHealth Inc.

GoHealth Inc is a health insurance marketplace and Medicare-focused digital health company whose purpose is to compassionately ensure consumers' peace of mind when making healthcare decisions, so it can focus on living life. It offers Medicare plans, including, but not limited to, Medicare Advantage, Medicare Supplement and prescription drug plans. The proprietary technology platform integrates artificial intelligence and modern machine-learning algorithms, powered by over two decades of insurance purchasing behavior, to reimagine the process of matching a health plan to a consumer's specific needs.

About INTS Intensity Therapeutics Inc.

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

Share on Social Networks: